INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

21,284 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
23
BP
Burnett PatrickSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$64K
2,607 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

Page 531 of 533
← PrevNext →
23
MM
Matsuda MasaruSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL
$177K
7,165 sh
Nov 3, 2025
Nov 5, 2025
traded Nov 3, 2025
+2d
SEC Form 4

Evidence

23
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$1.39M
7,619 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

23
QM
Quigley Jill M.Director
TERNTerns Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$441K
24.5K sh
Nov 4, 2025Nov 5, 2025
traded Nov 4, 2025
+1dSEC Form 4

Evidence

23
SH
Shulman Douglas H.Director, President & CEO
OMFOneMain Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$2.08M
35.0K sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

22
AL
Alpern Paul LVP and General Counsel
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$66K
5,000 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

21
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$750K
3,667 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

21
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$820K
3,992 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

21
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$467K
2,305 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

21
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$792K
3,834 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

21
WM
Wensveen MaartenEVP & Chief Technology Officer
CMPRCIMPRESS plc
Open-market sale
SELL$37K
526 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

21
SS
Singh SumitDirector, Chief Executive Officer
CHWYChewy, Inc.
Open-market sale · 10b5-1 plan
SELL$533K
16.3K sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

20
SM
Stetz MattiasChief Operating Officer
RSIRush Street Interactive, Inc.
Open-market sale · 10b5-1 plan
SELL$513K
30.0K sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

20
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$783K
4,286 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

20
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$600K
3,243 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

20
BP
Burnett PatrickSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$381
15 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

20
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$742K
4,032 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

20
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$676K
3,636 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

20
HC
Howse CurtisSee remarks
SYFSynchrony Financial
Open-market sale · 10b5-1 plan
SELL$895K
12.1K sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

20
LA
Lezack AdamDirector
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
1,368 sh
Oct 31, 2025Nov 5, 2025
traded Oct 31, 2025
+5dSEC Form 4

Evidence

20
PM
Palasis MariaDirector
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$35K
1,287 sh
Oct 31, 2025Nov 5, 2025
traded Oct 31, 2025
+5dSEC Form 4

Evidence

20
RM
Rothberg Jonathan MDirector, 10% Owner
BFLYButterfly Network, Inc.
Open-market sale · 10b5-1 plan
SELL$309K
100.5K sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

20
VL
Vairavan LathaSVP Chief Financial Officer
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$2,175
88 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

20
HR
Howard Justyn RussellDirector, Executive Chair, 10% Owner
SPTSprout Social, Inc.
Open-market sale · 10b5-1 plan
SELL$204K
20.0K sh
Nov 4, 2025Nov 5, 2025
traded Nov 4, 2025
+1dSEC Form 4

Evidence

20
WT
Watanabe ToddDirector, See Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1,753
69 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

20
MM
Matsuda MasaruSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1,092
43 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

19
BP
Burnett PatrickSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$92K
3,864 sh
Nov 5, 2025Nov 5, 2025
traded Nov 5, 2025
+0dSEC Form 4

Evidence

18
SS
Singh SumitDirector, Chief Executive Officer
CHWYChewy, Inc.
Open-market sale · 10b5-1 plan
SELL$75K
2,289 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

18
MS
Mehta SatishChief Technology Officer
CHWYChewy, Inc.
Open-market sale · 10b5-1 plan
SELL$108K
3,288 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

17
OD
Owens DarrellSee remarks
SYFSynchrony Financial
Open-market sale · 10b5-1 plan
SELL$221K
2,989 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

16
LA
Lezack AdamDirector
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$1,053
38 sh
Oct 31, 2025Nov 5, 2025
traded Oct 31, 2025
+5dSEC Form 4

Evidence

16
PM
Palasis MariaDirector
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$3,267
119 sh
Oct 31, 2025Nov 5, 2025
traded Oct 31, 2025
+5dSEC Form 4

Evidence

16
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$263K
1,400 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

16
SH
Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$39K
9,722 sh
Nov 5, 2025Nov 5, 2025
traded Nov 5, 2025
+0dSEC Form 4

Evidence

16
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$95K
3,776 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

16
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$294K
1,572 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

15
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$24K
127 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

15
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$9,323
49 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

15
KM
Kidd MarkEVP, GM Data Centers & ALM
IRMIRON MOUNTAIN INC
Open-market sale · 10b5-1 plan
SELL$615K
6,000 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence

15
BG
Billings William G.Chief Accounting Officer
CHWYChewy, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
1,121 sh
Nov 3, 2025Nov 5, 2025
traded Nov 3, 2025
+2dSEC Form 4

Evidence